Midas Mediscience Ltd is seeking collaborators to help extend the utility of DrugPrint®, a novel, multicellular, human cardiac tissue model for predictive ion channel profiling and cardiotoxicity screening. DrugPrint® combines a well-characterised multicellular human cardiac tissue model with powerful analytical pattern recognition software; providing a highly sensitive, real-time analysis of the effect of drugs and chemicals alone, in combinations and at a range of concentrations, on multiple human ion channels. The model has been validated with a library of known cardiotoxic reference compounds. Industrial and academic collaborators are sought to expand the utility of DrugPrint® in multiple directions. For further information please see the flyer.